Search by Drug Name or NDC

NDC 61919-0372-90 ENALAPRIL MALEATE 5 mg/1 Details

ENALAPRIL MALEATE 5 mg/1

ENALAPRIL MALEATE is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by DIRECT RX. The primary component is ENALAPRIL MALEATE.

MedlinePlus Drug Summary

Enalapril is used alone or in combination with other medications to treat high blood pressure. It is also used in combination with other medications to treat heart failure. Enalapril is in a class of medications called angiotensin-converting enzyme (ACE) inhibitors. It works by decreasing certain chemicals that tighten the blood vessels, so blood flows more smoothly and the heart can pump blood more efficiently. High blood pressure is a common condition, and when not treated it can cause damage to the brain, heart, blood vessels, kidneys, and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.

Related Packages: 61919-0372-90
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Enalapril

Product Information

NDC	61919-0372
Product ID	61919-372_fc5dd378-9514-949b-e053-6394a90a3ca2
Associated GPIs	36100020100305
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	ENALAPRIL MALEATE
Proprietary Name Suffix	n/a
Non-Proprietary Name	ENALAPRIL MALEATE
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET
Route	ORAL
Active Ingredient Strength	5
Active Ingredient Units	mg/1
Substance Name	ENALAPRIL MALEATE
Labeler Name	DIRECT RX
Pharmaceutical Class	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA075483
Listing Certified Through	2024-12-31

Package

NDC 61919-0372-90 (61919037290)

Pricing Information	N/A
NDC Package Code	61919-372-90
Billing NDC	61919037290
Package	90 TABLET in 1 BOTTLE (61919-372-90)
Marketing Start Date	2019-08-16
NDC Exclude Flag	N